Pembrolizumab is an immune checkpoint inhibitor that helps the immune system fight cancer. It targets the PD-1 protein on immune cells, allowing them to recognize and attack cancer cells. It is approved for many cancer types including melanoma, lung cancer, and head and neck cancers.
Pembrolizumab
Brand names: Keytruda
Pembrolizumab is an immune checkpoint inhibitor that helps the immune system fight cancer. It targets the PD-1 protein on immune cells, allowing them to recognize and attack cancer cells. It is approv
Ask Health.AI about PembrolizumabAt a Glance
- What is it?
- Pembrolizumab is an immune checkpoint inhibitor that helps the immune system fight cancer. It targets the PD-1 protein on immune cells, allowing them
- Drug Class
- PD-1 Inhibitor (Immunotherapy)
Overview
Ask Health.AI about Pembrolizumab
Get instant answers from our AI health assistant
Sources & References
- FDA Drug Label Information — fda.gov
- National Library of Medicine (DailyMed) — dailymed.nlm.nih.gov
- MedlinePlus Drug Information — medlineplus.gov
- American Pharmacists Association — pharmacist.com
- National Institutes of Health (NIH) — nih.gov
Was this helpful?